FR2230358A2 - Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine - Google Patents
Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamineInfo
- Publication number
- FR2230358A2 FR2230358A2 FR7417407A FR7417407A FR2230358A2 FR 2230358 A2 FR2230358 A2 FR 2230358A2 FR 7417407 A FR7417407 A FR 7417407A FR 7417407 A FR7417407 A FR 7417407A FR 2230358 A2 FR2230358 A2 FR 2230358A2
- Authority
- FR
- France
- Prior art keywords
- contg
- solns
- antihistamine
- cpd
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001387 anti-histamine Effects 0.000 title abstract 2
- 239000000739 antihistaminic agent Substances 0.000 title abstract 2
- 229940109248 cromoglycate Drugs 0.000 title 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 abstract 2
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 abstract 1
- QYXRRGWQSDDSMH-UHFFFAOYSA-N 5-[2-hydroxy-3-(2-oxochromen-5-yl)oxypropoxy]chromen-2-one Chemical compound O1C(C=CC2=C(C=CC=C12)OCC(COC1=C2C=CC(OC2=CC=C1)=O)O)=O QYXRRGWQSDDSMH-UHFFFAOYSA-N 0.000 abstract 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 208000030880 Nose disease Diseases 0.000 abstract 1
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 229960002469 antazoline Drugs 0.000 abstract 1
- REYFJDPCWQRWAA-UHFFFAOYSA-N antazoline Chemical compound N=1CCNC=1CN(C=1C=CC=CC=1)CC1=CC=CC=C1 REYFJDPCWQRWAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001857 anti-mycotic effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000002543 antimycotic Substances 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 239000008121 dextrose Substances 0.000 abstract 1
- 229960000520 diphenhydramine Drugs 0.000 abstract 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003352 sequestering agent Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000005526 vasoconstrictor agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2523873 | 1973-05-25 | ||
| GB2523773A GB1473318A (en) | 1973-05-25 | 1973-05-25 | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof |
| GB3332573 | 1973-07-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2230358A2 true FR2230358A2 (en) | 1974-12-20 |
| FR2230358B2 FR2230358B2 (enExample) | 1979-02-23 |
Family
ID=27258426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7417407A Granted FR2230358A2 (en) | 1973-05-25 | 1974-05-20 | Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5756448B2 (enExample) |
| DE (1) | DE2425281A1 (enExample) |
| FR (1) | FR2230358A2 (enExample) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2399249A1 (fr) * | 1977-08-01 | 1979-03-02 | American Home Prod | Compositions ophtalmiques contenant de l'acide 1,3-dioxo-1h-benz(d,e)isoquinoline-2(3h)-acetique |
| FR2573652A1 (fr) * | 1984-11-23 | 1986-05-30 | Fisons Ltd | Composition aqueuse de cromoglycate de sodium |
| EP0153003A3 (en) * | 1984-02-01 | 1986-11-26 | FISONS plc | Pharmaceutical formulations containing sodium cromoglycate |
| EP0201537A4 (en) * | 1984-10-23 | 1987-07-06 | Nastech Pharm Co | NEW USE OF ANTI-NAUSEA AND ANTI-EMETICS AGENTS. |
| US4729997A (en) * | 1985-10-15 | 1988-03-08 | Nastech Pharmaceutical Co., Inc. | Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same |
| US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
| WO1993021903A1 (en) * | 1992-05-06 | 1993-11-11 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| US5811466A (en) * | 1992-05-06 | 1998-09-22 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1582362A (en) * | 1977-03-17 | 1981-01-07 | Fisons Ltd | Cromoglycic acid salts and compositions |
| JPS5413575A (en) * | 1977-07-04 | 1979-02-01 | Nippon Telegr & Teleph Corp <Ntt> | Production of high polymer piezoelectric material |
| JPS57171914A (en) * | 1981-04-17 | 1982-10-22 | Tokai Daigaku | Antiallergic eye drop |
| RU2123327C1 (ru) * | 1996-05-27 | 1998-12-20 | Вилен Гургенович Петросян | Капли петросяна n 1 (n 2 - n 7 их варианты) для лечения аллергических и неатопических заболеваний глаз и носа |
| JP3508592B2 (ja) | 1998-12-21 | 2004-03-22 | 日産自動車株式会社 | 吸音ダクト構造体 |
| WO2005003111A1 (ja) * | 2003-07-04 | 2005-01-13 | Astellas Pharma Inc. | ウィルス性結膜炎の予防または治療剤 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1399834A (en) * | 1971-05-12 | 1975-07-02 | Fisons Ltd | Pharmaceutical compositions |
-
1974
- 1974-05-20 FR FR7417407A patent/FR2230358A2/fr active Granted
- 1974-05-24 DE DE19742425281 patent/DE2425281A1/de not_active Withdrawn
- 1974-05-24 JP JP49058021A patent/JPS5756448B2/ja not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2399249A1 (fr) * | 1977-08-01 | 1979-03-02 | American Home Prod | Compositions ophtalmiques contenant de l'acide 1,3-dioxo-1h-benz(d,e)isoquinoline-2(3h)-acetique |
| EP0153003A3 (en) * | 1984-02-01 | 1986-11-26 | FISONS plc | Pharmaceutical formulations containing sodium cromoglycate |
| EP0201537A4 (en) * | 1984-10-23 | 1987-07-06 | Nastech Pharm Co | NEW USE OF ANTI-NAUSEA AND ANTI-EMETICS AGENTS. |
| US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
| EP0183457A3 (en) * | 1984-11-23 | 1987-04-15 | Fisons Plc | Aqueous composition containing sodium cromoglycate |
| FR2573652A1 (fr) * | 1984-11-23 | 1986-05-30 | Fisons Ltd | Composition aqueuse de cromoglycate de sodium |
| US4729997A (en) * | 1985-10-15 | 1988-03-08 | Nastech Pharmaceutical Co., Inc. | Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same |
| WO1993021903A1 (en) * | 1992-05-06 | 1993-11-11 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| US5342620A (en) * | 1992-05-06 | 1994-08-30 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| US5811466A (en) * | 1992-05-06 | 1998-09-22 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| US6143799A (en) * | 1992-05-06 | 2000-11-07 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| US6365636B1 (en) | 1992-05-06 | 2002-04-02 | Alcon Manufacturing, Ltd. | Use of borate-polyol complexes in ophthalmic compositions |
| US6503497B2 (en) | 1992-05-06 | 2003-01-07 | Alcon Manufacturing, Ltd. | Use of borate-polyol complexes in ophthalmic compositions |
| US6849253B2 (en) | 1992-05-06 | 2005-02-01 | Alcon Manufacturing, Ltd. | Use of borate-polyol complexes in ophthalmic compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5756448B2 (enExample) | 1982-11-30 |
| JPS5040720A (enExample) | 1975-04-14 |
| FR2230358B2 (enExample) | 1979-02-23 |
| DE2425281A1 (de) | 1974-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2230358A2 (en) | Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine | |
| ES2188604T3 (es) | Inhibidores de proteasa del vih en combinaciones farmaceuticas para eltratamiento del sida. | |
| AR247326A1 (es) | Una composicion hipotonica acuosa para lentes de contacto. | |
| DK1090914T3 (da) | Forbindelser, der inhiberer retroviral protease | |
| AR247565A1 (es) | Metodo de preparacion de compuestos de piperidina terapeuticamente activos | |
| ES2112880T3 (es) | Inhibidores de la proteasa de vih utiles para el tratamiento del sida. | |
| ATE61050T1 (de) | Pyridazinamine wirksam gegen viren. | |
| ES2134764T3 (es) | Inhibidores de hiv proteasa. | |
| ES2063146T3 (es) | Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico. | |
| ES2177868T3 (es) | Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas. | |
| FI933393A0 (fi) | Agglomererade hydrofila komplex med flerfasiga frigoeringsegenskaper | |
| ES2032381T3 (es) | Un compuesto quimico. (reserva del art. 167.2 cpe). | |
| ES2150933T3 (es) | Inhibidores de la proteasa vih utiles para el tratamiento del sida. | |
| ATE450265T1 (de) | Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält | |
| IE810785L (en) | Anti-inflammatory ophthalmic composition | |
| ES2163506T3 (es) | Derivados de bencimidazolona con actividad dopaminergica central. | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| MX9305248A (es) | Compuestos de diarilpiperazinoacetamida. | |
| ES2183817T3 (es) | Inibidores de proteasas de parasatiso metazoarios. | |
| ES2101252T3 (es) | Inhibidores de la proteasa del hiv utiles para el tratamiento del sida. | |
| ES2152016T3 (es) | Solucion oftalmica de pranoprofeno conteniendo amina organica. | |
| ES2076190T3 (es) | Uso de fluor que contiene derivados del acido piridona-carboxilico para la preparacion de un medicamento para el tratamiento de las infecciones causadas por hiv. | |
| EP0396748A4 (en) | Agent for treating ischemic brain trouble | |
| ES2033379T3 (es) | Soluciones acuosas de clorhidrato de doxorubicina. | |
| ES2113938T3 (es) | Isomeros opticos de 7-(3-(1,1-dialquilmetil-1-amino)-1-pirrolidinil)-quinolonas y naftiridonas utilizados como agentes antibacterianos. |